Pharmaceutical
News, views and contacts from the global Pharmaceutical industry
22 January 2017
DAILY UPDATE
Industry News

M&As this week: Bio-Rad Labs, Eli Lilly
Bio-Rad Laboratories has reached an agreement to acquire US-based biotechnology company RainDance Technologies in order to expand into next-generation sequencing applications and foster its position in Droplet Digital PCR.

Australia’s Telix completes product collaboration agreement with Atlab Pharma
Australia’s Telix Pharmaceuticals has completed a product collaboration and purchase option agreement with Atlab Pharma.

Eli Lilly to acquire US company CoLucid Pharmaceuticals for $960m
Eli Lilly and Company has signed an agreement to acquire US-based CoLucid Pharmaceuticals in a transaction worth approximately $960m.

Deals this week: Shenzhen Kangtai Biological Products, Telix Pharmaceuticals, Fresenius Finance Ireland
Chinese vaccine and biologic products developer and manufacturer Shenzhen Kangtai Biological Products has announced the pricing for an initial public offering (IPO) of shares to raise ¥138.2m ($20.08m) in gross proceeds.

Press Releases

MediSapiens Joins Harmony Project for Better Care of Patients with Blood Diseases
Finnish bio-technology company MediSapiens is the latest organisation to join the HARMONY project, a newly established initiative aiming to provide better access and care for patients suffering from various blood diseases, through data sharing and collaborative treatment development.

Pharmaceutical Security Label Combines Multi-functional Counterfeiting Protection with Digital Features
At Pharmapack in Paris, Schreiner MediPharm will be presenting its extensive portfolio of customised pharmaceutical security solutions to safeguard the supply chain in Hall 4, Stand M31.

OPTIMA Life Science to Exhibit at ICE in Munich
OPTIMA Life Science has announced it will be attending ICE, an exhibit for paper, film, and foil converting.

CPL to Exhibit at CPhI North America
CPL has announced it will be showcasing its products at CPhI North America.

A Brief Summary of Seven Different 505(b)(2) Approvals
PDG® has compiled a brief summary of seven different 505(b)(2) approvals, including notable features and a tabular overview of each.

White Papers

Klocke uses NA and ML for Quality Storage
The KLOCKE Group manufactures and packages pharmaceutical products, food supplements and cosmetic...

Testing Parenteral Products for Micro Leaks, Container Closure Integrity Test
The E-Scan 655 tests container closure integrity in syringes, vials, and other liquid-filled parenteral...

Child Safe Compliance Packaging Wherever You Are in the World
Origin Pharma's lightweight child-resistant closure provides an effective line of defense against child access to pharmaceuticals....

Determination of Absorption of Isopropyl Myristate in Processing Equipment and Packaging Material by Liquid Extraction and Gas Chromatography
Isopropyl myristate (IPM) is widely used as a penetration enhancer and emollient in topical...

Porton Biopharma (PBL) Brochure
Porton Biopharma (PBL) manufactures the UK's licensed anthrax vaccine for and on behalf of the UK...

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.pharmaceutical-technology.com is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.